


Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Community
Ask the community for help and clear up your study doubts
Discover the best universities in your country according to Docsity users
Free resources
Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors
The new research considers that the drug can be precisely effective without harming innocent people. Scientists at Northwestern University have designed nanoparticles that can be used to target antigen-presenting cells instead of T cells, which rapamycin typically targets, allowing for more targeted and controllable immunosuppression.
Typology: Summaries
1 / 4
This page cannot be seen from the preview
Don't miss anything!
Because the patient's immune system destroys normal islet cells, after losing the function of the islets, they cannot control their blood sugar levels. In addition to insulin injections, islet transplantation has also emerged as a potential treatment for type 1 diabetes. But after transplantation, the immune system will attack the transplanted islets, and patients need to take long-term immunosuppressive drugs and endure the accompanying side effects of the drugs. How can patients reduce the side effects of immunosuppressive drugs? New research published in Nature Nanotechnology brings a new idea. Scientists have designed a nanocervator loaded with the commonly used immunosuppressant rapamycin that can target specific immune cells in question without causing widespread immunosuppression.
Rapamycin is already used in many treatments and transplants to suppress negative immune responses, but it is usually administered orally and therefore affects many cell types. Too high a dose may produce toxic side effects, and too low a dose may not protect the transplanted tissues and organs. The new research considers that the drug can be precisely effective without harming innocent people. Scientists at Northwestern University have designed nanoparticles that can be used to target antigen-presenting cells instead of T cells, which rapamycin typically targets, allowing for more targeted and controllable immunosuppression. The nanoparticles can be injected subcutaneously with the drug, preventing liver damage that can occur after taking it orally. The system works in theory, but what about in practice? ▲Design ideas for new research (Image source: Reference [2]) From the experimental results in mice, the actual effect of nanoparticles is very optimistic. The researchers first created a group of diabetic mice and then gave them islet transplants. One group of mice remained on oral rapamycin and the other group received injections of the nanoparticle drug. According to long-term observations, the mice in the injected group had far fewer side effects than the control group, and their diabetes was completely cured about 100 days after the transplant. Compared with the control group, the mice treated with the nanoparticles still maintained a higher immune response but did not impair the function of the transplanted islets.
[2] Guillermo Ameer, Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability, Nature Nanotechnology (2022). DOI: 10.1038/s41565-021-01048-2. Related articles: [1] Antidiabetic Drugs Classification and Mechanism of Action [2] Nature: A 100-year History of The Human Fight Against Diabetes